<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Ukraine</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Ukraine.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/ua.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Sat, 07 Nov 2026 03:45:11 GMT</lastBuildDate>
  <item>
    <title>Awareness regarding the epidemiology, prevention, treatment, and consequences of viral hepatitis among a predominantly young adult population in the Podillia region (Ukraine): a cross-sectional study</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-pmedr-2026-103644-50a2edb9/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-pmedr-2026-103644-50a2edb9/</guid>
    <pubDate>Sun, 01 Nov 2026 00:00:00 GMT</pubDate>
    <description>Understanding knowledge gaps and their predictors is relevant to hepatitis elimination efforts, as awareness of epidemiology, prevention, and treatment represents a foundational barrier to public health goals in the region.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis A</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Pharmacoeconomic analysis of opioid substitution therapy as a tool for HIV infection prevention in Ukraine</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-32352-0367-3057-5-26-04-a3a2980f/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-32352-0367-3057-5-26-04-a3a2980f/</guid>
    <pubDate>Wed, 28 Oct 2026 00:00:00 GMT</pubDate>
    <description>Results indicate that scaling OST in Ukraine is economically attractive and yields HIV prevention benefit alongside treatment value for opioid dependence.</description>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Evolution and global distribution of a pre-extensively drug-resistant Mycobacterium tuberculosis clade centred in Belarus</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1038-s44259-026-00265-w-655bf7ff/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1038-s44259-026-00265-w-655bf7ff/</guid>
    <pubDate>Sat, 05 Sep 2026 00:00:00 GMT</pubDate>
    <description>The authors state the results inform TB control in low- and high-burden settings and show drug-resistant TB as an interconnected global issue.</description>
    <category>Tuberculosis</category>
    <category>Antimicrobial resistance</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Crimean-Congo hemorrhagic fever: An emerging threat in Europe.</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-virs-2025-12-006-d7b8054a/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-virs-2025-12-006-d7b8054a/</guid>
    <pubDate>Mon, 15 Dec 2025 00:00:00 GMT</pubDate>
    <description>The resulting at-risk inventory may guide agencies in initiating or upgrading monitoring efforts where gaps exist.</description>
    <category>Hemorrhagic Fever</category>
    <category>Crimean-Congo hemorrhagic fever</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2025-30-29-2500015-2065327f/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2025-30-29-2500015-2065327f/</guid>
    <pubDate>Thu, 24 Jul 2025 00:00:00 GMT</pubDate>
    <description>The authors state the findings indicate substantial lifetime exposure and reinforce the need for sustained prevention, screening, treatment, and awareness to reduce transmission.</description>
    <category>Hepatitis B</category>
    <category>COVID-19</category>
    <category>Hepatitis C</category>
    <category>Hepatitis D</category>
    <category>SARS</category>
    <category>Hepatitis E</category>
    <category>Viral Hepatitis</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-24-02847-2-80172df1/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-24-02847-2-80172df1/</guid>
    <pubDate>Tue, 01 Apr 2025 00:00:00 GMT</pubDate>
    <description>The findings do not support using these digital adherence technologies alone to improve programmatic tuberculosis treatment outcomes. The abstract indicates that decisions should also consider economic evaluation, patient and stakeholder preferences, and other important patient outcomes.</description>
    <category>Tuberculosis</category>
    <category>Multidrug-resistant tuberculosis</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-12-2400094-df43daf3/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-12-2400094-df43daf3/</guid>
    <pubDate>Thu, 21 Mar 2024 00:00:00 GMT</pubDate>
    <description>The abstract identifies targeted health services for displaced Ukrainians as important for earlier diagnosis and treatment and for limiting transmission.</description>
    <category>Tuberculosis</category>
    <category>Antimicrobial resistance</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A clinical utility evaluation of dual HIV/Syphilis point-of-care tests in non-clinical settings for screening for HIV and syphilis in men who have sex with men</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09017-5-86a7fcc8/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09017-5-86a7fcc8/</guid>
    <pubDate>Thu, 29 Feb 2024 00:00:00 GMT</pubDate>
    <description>The abstract suggests dual POCTs could enable scaling up integrated HIV/syphilis testing for MSM through community-based, non-clinical services.</description>
    <category>Syphilis</category>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Management of drug-resistant tuberculosis</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-19-31882-3-fede5636/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-19-31882-3-fede5636/</guid>
    <pubDate>Sun, 01 Sep 2019 00:00:00 GMT</pubDate>
    <description>Drug-resistant tuberculosis is a major concern where proportions exceed 25% in some regions, and better diagnosis and treatment are needed to reduce harm.</description>
    <category>Tuberculosis</category>
    <category>Multidrug-resistant tuberculosis</category>
    <category>Antimicrobial resistance</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-017-2908-5-b2370c65/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-017-2908-5-b2370c65/</guid>
    <pubDate>Tue, 16 Jan 2018 00:00:00 GMT</pubDate>
    <description>The findings identify migrants from endemic countries as a population with a substantial estimated share of chronic hepatitis C infections, supporting consideration of targeted case-finding and treatment initiatives in secondary prevention planning.</description>
    <category>Hepatitis C</category>
    <category>Chronic hepatitis C</category>
    <category>Chronic viral hepatitis</category>
    <category>Viral Hepatitis</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1093-cid-cix499-b19a9332/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1093-cid-cix499-b19a9332/</guid>
    <pubDate>Mon, 29 May 2017 00:00:00 GMT</pubDate>
    <description>The findings provide study-specific evidence that molecular clustering analysis can characterize HIV transmission connectivity across risk groups among diagnosed individuals in Kiev during the study period. The abstract does not establish current population-wide burden or evaluate an intervention.</description>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Genomic epidemiology</category>
    <category>Transmission dynamics</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>HIV/AIDS surveillance in Europe: update 2007</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-2807-ese-13-50-19066-en-4e32b863/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-2807-ese-13-50-19066-en-4e32b863/</guid>
    <pubDate>Thu, 11 Dec 2008 00:00:00 GMT</pubDate>
    <description>Surveillance data are described as vital for tracking HIV epidemic trends and evaluating public health responses in Europe.</description>
    <category>AIDS</category>
    <category>HIV infection</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
